Ruti Aga's Six Years: Two for a Drug, Four for a Forged Prescription

Open the arithmetic of a six-year ban and the split looks wrong. Two years were served for a drug; four years for a piece of paper. The drug was one that cannot make a marathon faster — methylprednisolone, an ordinary anti-inflammatory injected into a swollen knee. The paper was a prescription bearing the stamp of a doctor whose clinic did not exist. Two-thirds of the sanction was paid for something that was never in her body, only in her file.

Ruti Aga, 32, Ethiopian marathon runner. The Athletics Integrity Unit (AIU), in its statement released on a Thursday, confirmed a six-year ban counted from 10 September — the same date on which she had been provisionally suspended. The case begins at a half marathon in China in March, which she won, and after which the collected sample returned an adverse finding.

What the early reports left out matters as much as what they printed. The winning time from that March race is not in the AIU statement. The field strength is not in it. The scope of annulled results is not in it. Where the source is silent, I will not slide an estimate into the chair reserved for a fact. The one hard number the case gives us is a career clock: 32 plus six lands at 38.

The substance that was not a steroid

Several reports described methylprednisolone as a 'prohibited steroid' and stated that WADA classes it as performance-enhancing. That classification is wrong, and in this case the error is not small. Methylprednisolone is a glucocorticoid — class S9 on the WADA Prohibited List — not an anabolic steroid, which sits in S1. Under the current List, S9 glucocorticoids are prohibited in-competition only, and only by injection, oral or rectal routes. Creams, ointments and eye drops fall outside that boundary.

The hinge of the case was therefore never 'did she take a steroid'. The hinge was: when was the injection given, by which route, and was residue still present on race day. In road running the in-competition window opens at 23:59 on the day before the race, so an injection taken four days earlier is still caught inside that window if any residue remains. That technical detail rewrites the entire architecture of a defence.

It is also worth recording that glucocorticoids have no proven endurance benefit. Blunting pain and suppressing swelling is one thing; running 42 kilometres faster is another. The substance sits on the List because it enables concealment and pain tolerance, not because it builds capacity.

The knee injection that was legal, and the proof that was missing

The knee-injury explanation is medically credible, and that is the bitterest irony here. Intra-articular methylprednisolone for knee synovitis in distance runners is standard sports-medicine practice. Indian distance runners pass through the same injection between seasons and remain administratively clean, because the shot is given out-of-competition and the washout period is respected.

The trouble is that a real treatment is defended by real records. Aga had no records. She had a prescription. And when the prescription was examined, it broke — because it was built out of a relationship rather than a document.

I have watched track and road races for years, and one pattern returns: an athlete without a credentialed team physician treats injury through an informal network — a relative who is 'doctor sahab', an old acquaintance who once worked at a clinic, a pharmacy that releases an injection without a prescription. This is rarely a conspiracy. It is convenience. And convenience, placed in front of an investigation, becomes evidence.

Three checks, three failures

According to the AIU statement, the prescription was issued by a family member presenting as a doctor, holding no medical registration, who claimed to have used 'an old prescription pad from a former workplace'. The clinic named on that pad explicitly disowned both the employee and the pad. Three independent verifications — registration, clinic existence, source of the pad — all failed.

That is rare in doping cases. Disputes are usually technical: metabolites, chain of custody, the B sample, laboratory accreditation, therapeutic justification. Here there was nothing left to dispute, because the defence spent all its energy on a document that three separate checks exposed.

The lesson is administrative rather than medical. When you already hold the truth, the most dangerous thing you can do is decorate it. A genuine MRI, a genuine clinic receipt, a genuine date — with those three, the argument would have been about use, not about fabrication. And an argument about use leaves room to move under S9.

Two plus four equals six: what the panel refused

Break the number down. Two years for presence, four for tampering. Four is the Code's standard tampering sanction; two for presence implies the panel treated the substance as a Specified Substance and left intent somewhere between proven and unproven. What is missing is the no-significant-fault reduction, the provision that could have cut the presence sanction sharply.

The panel refused it, and the forged prescription is why. There is a paradox worth recording: false documentation is itself circumstantial evidence of intent to conceal, yet it did not aggravate the presence sanction — it attached as a separate charge and pushed the total past double. The jump from two years to six is the single largest data point in this file.

It also reveals where enforcement priorities now sit. The anti-doping system is weighing paper more heavily than pharmacology. An athlete who tells the truth serves two years; an athlete who fabricates to escape serves six. The system's message is legible whether or not one approves of it.

10 September is procedure, not relief

Several accounts framed the backdating to 10 September as a concession. It is not. Time served under provisional suspension counts against the ban, so the athlete gains nothing in real terms; only the paperwork straightens out. The total remains six years.

Two things are genuinely absent from the source: the year of the March race, and the end date of the ban. The statement says 'Thursday', and dates the provisional suspension to 10 September, which implies the current cycle. Where the year is not printed, I will not add one. The plain arithmetic reads: six years forward from 10 September.

The career ledger: 32 to 38

A 38-year-old marathoner carrying a doping record is not a selectable athlete inside Ethiopian women's depth. The queue contains sub-2:16 performers; a 2:18–2:20 athlete was never automatically picked even before this. That is not her weakness; it is her country's surplus.

The real ban, then, is not six years. It is the remainder of a career. In the East African road-racing economy, injury management is a permanent pressure: appearance fees arrive in the same week as the race, and the knee speaks in the same week as the briefing. Suppressing pain becomes an economic decision rather than a moral one, and glucocorticoids are the cheapest tool available.

I opened the notebook and the stadium started talking. One line in it reads Tokyo 2026 — a win, 2:20:40, from public race records, since the AIU statement gives no mark. Before that, Berlin 2026, second in 2:18:34. That is a level that is not produced every weekend, and it is now filed under a heading called tampering.

What survives survives in the record book

The Tokyo title, the three World Marathon Majors second places and the 2:18 level remain in the sport's history. The violation attaches to the March race. Standard AIU practice voids the result and prize money from the competition where the sample was collected, along with ranking points accrued after that date. The source does not state the scope — and until it does, 2026 cannot be treated as erased.

That distinction carries commercial weight. Distance running sponsorship is thin to begin with, and a ban is the easiest line for a brand to cut.

China's label-race economy

This stops being one athlete's story quickly. For an AIU sample to exist at that March half marathon, the race must have carried in-competition testing — meaning a World Athletics Label event with an international elite field and a real prize purse. For East African marathoners, that tier has become a clean income bracket: fewer races in the gap months between Majors, decent appearance fees, contained risk.

It is also the AIU's highest-yield testing ground. Where the money is dense and the field is international, the samples will be dense too. The geography of earning and the geography of testing are now colliding in the same races.

Four years for words spoken aloud

The tampering sanction did not come from paper alone. Per the AIU statement, it also rests on statements made during the investigative interview. Words spoken under questioning carried the same price as the forged pad. Anyone who assumes an interview is a formality should note this.

Language and translation in AIU interviews with East African athletes have been a persistent objection — who interprets, how the record is built, which sentence is called a mistake and which a lie. That argument is legitimate and should not be suppressed. In this particular file it is weak, because a false document is not a language problem. It is a document problem.

India's empty space

Having logged road-race results for years, I recognise the gap here because Indian athletics carries the same one: a paper-thin medical support structure. The 'team doctor' a Railways or Services distance runner relies on is often a departmental physician, not a sports-medicine specialist.

TUE procedure, washout dates, route of administration — if a team does not hold those three, the next athlete who takes a knee injection stands exactly where Aga stands: the defence has the truth and no paper. On the day of the test, truth stops mattering.

Three venues, no crowd, and the data still sang — truer on the road, where there is no stadium at all. No stands, no tickets, no crowd noise. What remains is the start list, the splits and the sample. The third of those is now producing most of the news.

Contrarian: the yardstick is paper, not effect

Grant that the AIU applied the Code correctly. The question of who the Code costs most still stands. A glucocorticoid with no proven endurance benefit produced six years. Clean anabolic-steroid cases routinely produce four. That inconsistency will feed an argument already running: is the sanction calibrated to the substance or to the tidiness of the file?

In this case the answer is the file. And that is what hurts the poorest entourages most, because clean paperwork is itself a resource. An athlete without a lawyer, an agent and the time to keep records is not less culpable; she is simply caught more often.

Contrarian: this is testing data, not usage data

A second lazy conclusion will follow — that road running is getting dirtier. My ledger does not support it. This case does not show that use has risen; it shows that the frontier of enforcement has shifted from detection to document verification. When the frontier moves to documents, the count of caught athletes measures paperwork literacy, not dosage.

Correlation is not causation. AIU presence at Label races has grown, so cases from Label races have grown. That does not mean use grew there. Where no testing happens, use is not zero — it is merely unrecorded. The model is only as honest as its worst match, and road running's worst match is the one nobody filed a report about.

What to watch next

Three entries go into the notebook against this file. One: whether the March result and its prize money are formally annulled, because the AIU statement does not specify the scope. Two: whether a CAS appeal follows, typically within roughly 21 days of the reasoned decision — and if it does, the weakest link will be the four-year component resting on interview statements rather than on documents.

Three, and most important: whether the AIU ever charges an entourage. Every name in this statement is the athlete's, yet someone else produced the pad, someone advised, and the injection was administered somewhere. Until a sanction travels past the last link standing on the track, the same arithmetic will repeat — age 32, six years, one piece of paper.

Page 14 was where the season stopped lying. In this file, page 14 is the prescription stamped by a doctor who never existed. A number is a story that has not found its witness yet. Six years is the witness; the open question is whose conduct it testifies against.